Join to View Full Profile
160 E 34th StNew York, NY 10016
Phone+1 212-731-6667
Fax+1 646-754-9841
Dr. Spencer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rutgers Health/New Jersey Medical SchoolResidency, Emergency Medicine, 2013 - 2017- Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2017
Rowan University School of Osteopathic MedicineClass of 2011
Certifications & Licensure
NY State License 2022 - 2025
NJ State License 2012 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors Start of enrollment: 2021 Sep 07
- A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma Start of enrollment: 2021 Mar 22
Roles: Principal Investigator, Sponsor-Investigator, Contact
- Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer Start of enrollment: 2023 Mar 22
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.Lakshmi Rajdev, Gentry G King, Christopher H Lieu, Stacey A Cohen, Shubham Pant
JCO Precision Oncology. 2025-03-01 - 1 citationsAmplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and Barriers.Kristen Spencer, Henry Butenschoen, Emily Alger, Melinda Bachini, Natalie Cook
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01 - Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E.Eric X Chen, Petr Kavan, Mustapha Tehfe, Jeremy S Kortmansky, Michael B Sawyer
Clinical Colorectal Cancer. 2024-06-01
Press Mentions
Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and BarriersJune 1st, 2024- ECOG-ACRIN Adds Another Trial to the ComboMATCH Precision Oncology Study PlatformMay 8th, 2024
- Perlmutter Cancer Center Appoints New Clinical Trials Leadership, Expands Access to Early-Stage TrialsJuly 21st, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
